Endocrinology, 158(10), 31743187
Conclusion# Amycretin and CagriSema illustrate two philosophies for combining GLP-1 and amylin receptor activation
SS-31 (Elamipretide): The First FDA-Approved Mitochondrial Therapeutic In September 2025, the FDA granted accelerated approval to Forzinity (elamipretide), marking a watershed moment in mitochondrial medicine
GutBrain Axis and Appetite Signaling : Studying how peripheral hormones influence CNS circuits involved in hunger, satiety, food choice, and reward-related feeding behavior
By enhancing superoxide dismutase (SOD) activity and lowering reactive oxygen species, AHK-Cu offers a model for antioxidant research
Studies broadened into structural, vascular, and epithelial systems